| Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation (NCT02196857) | M.D. Anderson Cancer Center | 2015-02-06 |
| Ultralow Dose Thoracic Computed Tomography in Immunocompromised Patients (NCT02755480) | University Health Network, Toronto | 2015-02-01 |
| GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant (NCT02360111) | Memorial Sloan Kettering Cancer Center | 2015-02-01 |
| Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease (NCT02378701) | M.D. Anderson Cancer Center | 2015-02-01 |
| Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies (NCT02305979) | Wake Forest University Health Sciences | 2014-12-01 |
| A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma (NCT02349698) | Southwest Hospital, China | 2014-12-01 |
| IFN-DLI for Relapsed Acute Leukemia After Allo-SCT (NCT02331706) | Abramson Cancer Center at Penn Medicine | 2014-12-01 |
| Blood Samples to Identify Biomarkers of Busulfan (NCT02291965) | Fred Hutchinson Cancer Center | 2014-11-01 |
| Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies (NCT02223052) | Celgene | 2014-10-27 |
| Infusion of Allogeneic, 3rd Party CD19-specific T Cells (NCT02274506) | M.D. Anderson Cancer Center | 2014-10-20 |
| Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) (NCT02269280) | M.D. Anderson Cancer Center | 2014-10-13 |
| Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (NCT02323867) | Children's Hospital of Philadelphia | 2014-10-01 |
| A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leukemia (NCT02251548) | Dana-Farber Cancer Institute | 2014-10-01 |
| Exercise Post Bone Marrow Transplant (NCT02320942) | University of British Columbia | 2014-10-01 |
| Vincristine PK and PD in the AYA Population Compared to Younger Children (NCT02360930) | Children's Hospital Los Angeles | 2014-09-01 |
| MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy (NCT02089230) | M.D. Anderson Cancer Center | 2014-08-27 |
| Pre and Post Treatment Metabolomic Analysis of Leukemia: A Translational Clinical Trial of the Brown Cancer Center (NCT02193100) | University of Louisville | 2014-08-01 |
| A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase (NCT02272777) | Novartis Pharmaceuticals | 2014-07-17 |
| A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies (NCT02158858) | Constellation Pharmaceuticals | 2014-07-16 |
| Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America (NCT02559583) | Janssen-Cilag Ltd. | 2014-07-01 |
| Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation (NCT02328885) | Banc de Sang i Teixits | 2014-07-01 |
| Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection (NCT02095951) | Children's Hospital of Michigan | 2014-06-01 |
| Improving Patient Education for Lymphoma and Leukemia Inpatients (NCT02642510) | Emory University | 2014-06-01 |
| A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene (NCT02141828) | Epizyme, Inc. | 2014-05-01 |
| Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML) (NCT02096042) | M.D. Anderson Cancer Center | 2014-04-01 |
| Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children (NCT02129049) | University of Washington | 2014-04-01 |
| Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS) (NCT02010645) | M.D. Anderson Cancer Center | 2014-03-01 |
| Delayed Effects of Treatment in Cancer Survivors (DETECS) (NCT02067637) | University of Colorado, Denver | 2014-03-01 |
| Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) (NCT01895842) | M.D. Anderson Cancer Center | 2014-02-01 |
| MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis (NCT02270307) | National Research Center for Hematology, Russia | 2014-01-01 |
| Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene (NCT01875237) | M.D. Anderson Cancer Center | 2013-12-27 |
| Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL) (NCT01891981) | M.D. Anderson Cancer Center | 2013-12-17 |
| DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma (NCT00889408) | Masonic Cancer Center, University of Minnesota | 2013-12-02 |
| IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL) (NCT02028039) | M.D. Anderson Cancer Center | 2013-12-01 |
| Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC (NCT02356653) | Children's Hospital of Philadelphia | 2013-12-01 |
| Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion (NCT02053545) | Ann & Robert H Lurie Children's Hospital of Chicago | 2013-12-01 |
| Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies (NCT01919619) | M.D. Anderson Cancer Center | 2013-11-04 |
| Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60 (NCT02234037) | Emory University | 2013-11-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Known (NCT01971476) | Boehringer Ingelheim | 2013-10-22 |
| Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS) (NCT01893372) | M.D. Anderson Cancer Center | 2013-10-01 |
| A Feasibility Study of Prophylactic White Blood Cell Transfusions (NCT01932710) | M.D. Anderson Cancer Center | 2013-09-20 |
| Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis (NCT02065154) | University of Alabama at Birmingham | 2013-08-27 |
| A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia (NCT01920737) | Memorial Sloan Kettering Cancer Center | 2013-08-07 |
| Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation (NCT01891968) | M.D. Anderson Cancer Center | 2013-08-07 |
| Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant (NCT01904175) | Duke University | 2013-08-01 |
| Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome (NCT01893320) | M.D. Anderson Cancer Center | 2013-07-18 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL) (NCT01653717) | M.D. Anderson Cancer Center | 2013-06-11 |
| DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes (NCT00397579) | University of Texas Southwestern Medical Center | 2013-05-01 |
| Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders (NCT00968461) | M.D. Anderson Cancer Center | 2013-05-01 |
| Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia (NCT01319981) | M.D. Anderson Cancer Center | 2013-03-05 |
| Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501) (NCT01254318) | Merck Sharp & Dohme LLC | 2013-03-01 |
| Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload (NCT01508260) | M.D. Anderson Cancer Center | 2013-03-01 |
| Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR (NCT02043184) | Michigan State University | 2013-03-01 |
| Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia (NCT01794702) | M.D. Anderson Cancer Center | 2013-02-20 |
| Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors (NCT01608152) | M.D. Anderson Cancer Center | 2013-02-20 |
| Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML) (NCT01786343) | M.D. Anderson Cancer Center | 2013-02-05 |
| Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients (NCT01828619) | Peking University People's Hospital | 2013-02-01 |
| Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia (NCT01119586) | Children's Oncology Group | 2013-02-01 |
| Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia (NCT01138306) | Children's Oncology Group | 2013-02-01 |
| Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies (NCT01915992) | Assistance Publique Hopitaux De Marseille | 2013-02-01 |
| Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System (NCT01596127) | M.D. Anderson Cancer Center | 2013-01-24 |
| Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT) (NCT01490723) | M.D. Anderson Cancer Center | 2013-01-01 |
| Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL (NCT01752426) | M.D. Anderson Cancer Center | 2012-12-17 |
| Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells (NCT01362452) | M.D. Anderson Cancer Center | 2012-12-07 |
| Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings (NCT01755000) | Washington University School of Medicine | 2012-12-01 |
| Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL) (NCT01649622) | M.D. Anderson Cancer Center | 2012-12-01 |
| A Study for Tyrosine Kinase Inhibitors Discontinuation (NCT02897245) | Versailles Hospital | 2012-12-01 |
| Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (NCT01746849) | Memorial Sloan Kettering Cancer Center | 2012-12-01 |
| Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk (NCT01720225) | M.D. Anderson Cancer Center | 2012-11-06 |
| Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies. (NCT01728389) | Maria Sklodowska-Curie National Research Institute of Oncology | 2012-11-01 |
| Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies (NCT01682226) | Memorial Sloan Kettering Cancer Center | 2012-09-05 |
| Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia (NCT01057290) | Children's Oncology Group | 2012-09-01 |
| Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML) (NCT01460498) | M.D. Anderson Cancer Center | 2012-08-08 |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies (NCT01471067) | M.D. Anderson Cancer Center | 2012-07-13 |
| Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias (NCT01396499) | M.D. Anderson Cancer Center | 2012-07-01 |
| Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma (NCT01593696) | National Cancer Institute (NCI) | 2012-06-29 |
| An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357) (NCT01498445) | M.D. Anderson Cancer Center | 2012-06-12 |
| Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot (NCT01615146) | Ottawa Hospital Research Institute | 2012-06-01 |
| Efficacy Study of Low-dose Glucocorticoid Prophylaxis for Acute Graft-versus-host Disease(GVHD) (NCT01607580) | Peking University People's Hospital | 2012-06-01 |
| Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial (NCT01629745) | Children's Oncology Group | 2012-06-01 |
| Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation (NCT01596257) | Memorial Sloan Kettering Cancer Center | 2012-05-05 |
| Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia (NCT01626183) | Children's Oncology Group | 2012-05-01 |
| Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997 (NCT00899873) | ECOG-ACRIN Cancer Research Group | 2012-04-17 |
| Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning (NCT01572662) | M.D. Anderson Cancer Center | 2012-04-11 |
| S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia (NCT01575535) | SWOG Cancer Research Network | 2012-04-01 |
| Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP) (NCT01570868) | M.D. Anderson Cancer Center | 2012-04-01 |
| A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma (NCT01551628) | Bio-Cancer Treatment International Limited | 2012-04-01 |
| Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (NCT01553162) | Children's Oncology Group | 2012-04-01 |
| A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives (NCT01532635) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-03-01 |
| Empirical Versus Preemptive Antifungal Therapy (NCT01288378) | European Organisation for Research and Treatment of Cancer - EORTC | 2012-03-01 |
| Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies (NCT00943319) | University of Chicago | 2012-03-01 |
| Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS) (NCT01542684) | M.D. Anderson Cancer Center | 2012-03-01 |
| Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients (NCT01520519) | M.D. Anderson Cancer Center | 2012-02-27 |
| Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) (NCT01515527) | M.D. Anderson Cancer Center | 2012-02-07 |
| Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia (NCT01533168) | Children's Oncology Group | 2012-02-01 |
| Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial (NCT01507441) | Children's Oncology Group | 2012-02-01 |
| Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder (NCT01511575) | Children's Oncology Group | 2012-02-01 |
| Comparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid Leukemia (NCT01498302) | Children's Oncology Group | 2012-02-01 |